Optimisation of cost effectiveness through Individualised FSH Stimulation dosages for IVF Treatment: The OPTIMIST trial.

Completed

• Conditions: Infertility; Subfertility; 10038612

• Registration Number: NL-OMON38129
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1500

Inclusion Criteria

- Regular indication for IVF or IVF-ICSI
- Female age < 44 years
- Regular cycle (average length 25-35 days)
- No major uterine or ovarian abnormalities detected at TVS
- No previous IVF cycles or first IVF cycle after birth of a child
- Written informed consent

Exclusion Criteria

- Oocyte donation
- Medical contra indication for pregnancy or IVF treatment
- Polycystic Ovary Syndrome (PCOS)
- Untreated endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome will be live birth and costs based on previous calculations<br /><br>of the various study procedures</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes will be poor ovarian response, hyperresponse, cycle<br /><br>cancellation rates, number of cycles needed per live birth.</p><br>